SIMILAR PATTERNS OF AMINO ACIDS FOR 5NJV_A_SAMA301
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e08 | [FE]-HYDROGENASE(LARGE SUBUNIT) (Desulfovibriodesulfuricans) |
PF02906(Fe_hyd_lg_C)PF13187(Fer4_9) | 6 | GLY A 297GLY A 70GLY A 386GLY A 381VAL A 28ILE A 235 | PDT A 4 (-3.3A)SF4 A 2 (-3.8A)SF4 A 3 ( 4.3A)SF4 A 3 ( 3.9A)SF4 A 2 (-4.7A)None | 1.17A | 5njvA-1e08A:undetectable | 5njvA-1e08A:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eiz | FTSJ (Escherichiacoli) |
PF01728(FtsJ) | 5 | GLY A 59GLY A 64TRP A 65ASP A 99ASP A 124 | SAM A 301 (-3.6A)SAM A 301 (-3.1A)SAM A 301 (-3.6A)SAM A 301 (-3.5A)SAM A 301 (-3.6A) | 0.39A | 5njvA-1eizA:14.8 | 5njvA-1eizA:23.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ekq | HYDROXYETHYLTHIAZOLEKINASE (Bacillussubtilis) |
PF02110(HK) | 6 | GLY A 197GLY A 67GLY A 195THR A 68ASP A 94ILE A 66 | None | 1.38A | 5njvA-1ekqA:2.5 | 5njvA-1ekqA:21.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1elt | ELASTASE (Salmo salar) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 197GLY A 193VAL A 52ILE A 31 | None | 1.29A | 5njvA-1eltA:undetectable | 5njvA-1eltA:21.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ffv | CUTS, IRON-SULFURPROTEIN OF CARBONMONOXIDEDEHYDROGENASECUTL, MOLYBDOPROTEINOF CARBON MONOXIDEDEHYDROGENASE (Hydrogenophagapseudoflava;Hydrogenophagapseudoflava) |
PF00111(Fer2)PF01799(Fer2_2)PF01315(Ald_Xan_dh_C)PF02738(Ald_Xan_dh_C2) | 5 | GLY A 98GLY B 695GLY A 140THR B 698ILE B 693 | NoneARO B 384 ( 3.9A)NoneNoneNone | 0.87A | 5njvA-1ffvA:undetectable | 5njvA-1ffvA:22.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k4y | LIVERCARBOXYLESTERASE (Oryctolaguscuniculus) |
PF00135(COesterase) | 5 | GLY A 248GLY A 143GLY A 141GLY A 224ASP A 90 | None | 0.87A | 5njvA-1k4yA:undetectable | 5njvA-1k4yA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1l2q | MONOMETHYLAMINEMETHYLTRANSFERASE (Methanosarcinabarkeri) |
PF05369(MtmB) | 5 | GLY A 387GLY A 129GLY A 366THR A 131ILE A 156 | NoneNoneNoneXPL A 202 ( 4.5A)None | 0.74A | 5njvA-1l2qA:undetectable | 5njvA-1l2qA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mza | PRO-GRANZYME K (Homo sapiens) |
PF00089(Trypsin) | 5 | GLY A 44GLY A 142GLY A 193GLY A 196ASP A 145 | None | 0.89A | 5njvA-1mzaA:undetectable | 5njvA-1mzaA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1op2 | VENOM SERINEPROTEINASE (Deinagkistrodonacutus) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.29A | 5njvA-1op2A:undetectable | 5njvA-1op2A:19.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r6a | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 887 (-3.0A)SAH A 887 (-3.6A)SAH A 887 (-3.6A)SAH A 887 (-3.3A)SAH A 887 (-3.5A)SAH A 887 (-4.5A)SO4 A 901 ( 3.9A)SAH A 887 ( 3.3A)SAH A 887 (-3.5A)SAH A 887 (-3.9A)SAH A 887 ( 4.2A) | 0.45A | 5njvA-1r6aA:40.1 | 5njvA-1r6aA:59.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r6a | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132 | SAH A 887 (-3.0A)SAH A 887 (-3.6A)SAH A 887 (-3.6A)SAH A 887 (-3.3A)SAH A 887 (-3.5A)SAH A 887 (-4.5A)SO4 A 902 (-2.7A)SO4 A 901 ( 3.9A)SAH A 887 ( 3.3A)SAH A 887 (-3.5A) | 0.89A | 5njvA-1r6aA:40.1 | 5njvA-1r6aA:59.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vcw | PROTEASE DEGS (Escherichiacoli) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.82A | 5njvA-1vcwA:undetectable | 5njvA-1vcwA:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b25 | HYPOTHETICAL PROTEIN (Homo sapiens) |
PF08704(GCD14) | 5 | GLY A 111GLY A 113GLY A 116ASP A 173ASP A 192 | SAM A 601 (-2.9A)SAM A 601 (-3.2A)SAM A 601 (-3.5A)SAM A 601 (-3.4A)SAM A 601 (-3.5A) | 0.67A | 5njvA-2b25A:8.5 | 5njvA-2b25A:23.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cfb | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE (Synechococcuselongatus) |
PF00202(Aminotran_3) | 6 | GLY A 260GLY A 294GLY A 255GLY A 250THR A 297ILE A 295 | None | 1.45A | 5njvA-2cfbA:undetectable | 5njvA-2cfbA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2et6 | (3R)-HYDROXYACYL-COADEHYDROGENASE (Candidatropicalis) |
PF00106(adh_short) | 5 | GLY A 333GLY A 404GLY A 329GLY A 335ILE A 405 | None | 0.90A | 5njvA-2et6A:5.0 | 5njvA-2et6A:18.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nyu | PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2 (Homo sapiens) |
PF01728(FtsJ) | 5 | GLY A 30TRP A 36ASP A 79VAL A 80ASP A 104 | SAM A 201 (-3.5A)SAM A 201 (-3.9A)SAM A 201 (-3.3A)SAM A 201 (-3.9A)SAM A 201 (-3.7A) | 0.39A | 5njvA-2nyuA:14.1 | 5njvA-2nyuA:25.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2okj | GLUTAMATEDECARBOXYLASE 1 (Homo sapiens) |
PF00282(Pyridoxal_deC) | 5 | GLY A 351GLY A 379GLY A 346TRP A 376ILE A 480 | None | 0.88A | 5njvA-2okjA:undetectable | 5njvA-2okjA:18.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oxt | NUCLEOSIDE-2'-O-METHYLTRANSFERASE (Meaban virus) |
PF01728(FtsJ) | 9 | GLY A 59GLY A 82GLY A 84GLY A 87TRP A 88THR A 105HIS A 111ASP A 132ASP A 147 | SAM A 300 (-3.1A)SAM A 300 (-3.3A)SAM A 300 (-3.5A)SAM A 300 (-3.2A)SAM A 300 (-3.8A)SAM A 300 (-4.6A)SAM A 300 (-3.6A)SAM A 300 (-3.9A)SAM A 300 (-3.9A) | 0.44A | 5njvA-2oxtA:39.4 | 5njvA-2oxtA:51.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oxt | NUCLEOSIDE-2'-O-METHYLTRANSFERASE (Meaban virus) |
PF01728(FtsJ) | 6 | GLY A 82GLY A 59GLY A 87GLY A 84THR A 60ASP A 147 | SAM A 300 (-3.3A)SAM A 300 (-3.1A)SAM A 300 (-3.2A)SAM A 300 (-3.5A)NoneSAM A 300 (-3.9A) | 1.33A | 5njvA-2oxtA:39.4 | 5njvA-2oxtA:51.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 301 (-3.4A)SAH A 301 (-3.0A)SAH A 301 (-3.2A)SAH A 301 (-3.0A)SAH A 301 (-3.7A)SAH A 301 (-4.4A)SAH A 301 (-4.4A)SAH A 301 (-3.2A)SAH A 301 (-3.8A)SAH A 301 (-4.2A)SAH A 301 ( 4.3A) | 0.42A | 5njvA-2oy0A:40.0 | 5njvA-2oy0A:69.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147 | SAH A 301 (-3.4A)SAH A 301 (-3.0A)SAH A 301 (-3.2A)SAH A 301 (-3.0A)SAH A 301 (-3.7A)SAH A 301 (-4.4A)NoneSAH A 301 (-4.4A)SAH A 301 (-3.8A)SAH A 301 (-4.2A)SAH A 301 ( 4.3A) | 0.59A | 5njvA-2oy0A:40.0 | 5njvA-2oy0A:69.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 58TRP A 87HIS A 110ASP A 131ASP A 146ILE A 147 | SAH A 301 (-3.4A)SAH A 301 (-3.7A)SAH A 301 (-4.4A)SAH A 301 (-3.2A)SAH A 301 (-4.2A)SAH A 301 ( 4.3A) | 1.49A | 5njvA-2oy0A:40.0 | 5njvA-2oy0A:69.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 86TRP A 87LYS A 105HIS A 110ASP A 146ILE A 147 | SAH A 301 (-3.0A)SAH A 301 (-3.7A)NoneSAH A 301 (-4.4A)SAH A 301 (-4.2A)SAH A 301 ( 4.3A) | 1.38A | 5njvA-2oy0A:40.0 | 5njvA-2oy0A:69.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2px5 | GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)] (Murray Valleyencephalitisvirus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A) | 0.42A | 5njvA-2px5A:42.0 | 5njvA-2px5A:67.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2px5 | GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)] (Murray Valleyencephalitisvirus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SAH A 500 (-3.4A)SAH A 500 (-3.3A)SAH A 500 (-3.2A)SAH A 500 ( 3.7A)NoneSAH A 500 (-3.6A) | 1.32A | 5njvA-2px5A:42.0 | 5njvA-2px5A:67.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2px5 | GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)] (Murray Valleyencephalitisvirus) |
PF01728(FtsJ) | 8 | GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132 | SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.5A)SAH A 500 (-3.6A) | 0.86A | 5njvA-2px5A:42.0 | 5njvA-2px5A:67.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3u | PROTEASE DEGS (Escherichiacoli) |
PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.80A | 5njvA-2r3uA:undetectable | 5njvA-2r3uA:22.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wa2 | NON-STRUCTURALPROTEIN 5 (Modoc virus) |
PF01728(FtsJ) | 10 | GLY A 59GLY A 82GLY A 84TRP A 88THR A 105HIS A 111ASP A 132VAL A 133ASP A 147ILE A 148 | SAM A1248 ( 3.7A)SAM A1248 (-3.3A)SAM A1248 (-3.4A)SAM A1248 (-3.7A)SAM A1248 (-4.5A)SAM A1248 (-3.8A)SAM A1248 (-3.6A)SAM A1248 (-3.4A)SAM A1248 (-3.7A)SAM A1248 ( 4.0A) | 0.36A | 5njvA-2wa2A:32.8 | 5njvA-2wa2A:50.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xn8 | PUTATIVE CYTOCHROMEP450 125 (Mycobacteriumtuberculosis) |
PF00067(p450) | 5 | GLY A 56GLY A 60GLY A 62GLY A 69ASP A 58 | None | 0.73A | 5njvA-2xn8A:undetectable | 5njvA-2xn8A:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (Severe acuterespiratorysyndrome-relatedcoronavirus) |
PF06460(NSP13) | 5 | GLY A 71GLY A 73GLY A 81ASP A 114ASP A 130 | SAH A1293 (-3.8A)SAH A1293 (-4.1A)SAH A1293 (-3.6A)SAH A1293 (-3.7A)SAH A1293 (-3.7A) | 0.89A | 5njvA-2xyqA:10.6 | 5njvA-2xyqA:20.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z8z | LIPASE (Pseudomonas sp.MIS38) |
PF00353(HemolysinCabind) | 5 | GLY A 505GLY A 520GLY A 523ASP A 516ASP A 507 | None CA A 626 ( 4.6A) CA A 624 ( 3.3A) CA A 623 ( 2.3A)None | 0.89A | 5njvA-2z8zA:undetectable | 5njvA-2z8zA:17.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dou | RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J (Thermoplasmavolcanium) |
PF01728(FtsJ) | 5 | GLY A 46GLY A 51TRP A 52ASP A 83ASP A 111 | SAM A 1 (-3.5A)SAM A 1 (-3.2A)SAM A 1 (-4.0A)SAM A 1 (-3.6A)SAM A 1 (-3.7A) | 0.45A | 5njvA-3douA:13.9 | 5njvA-3douA:19.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3elu | METHYLTRANSFERASE (Wesselsbronvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110VAL A 132ASP A 146ILE A 147 | SAM A4633 ( 3.7A)SAM A4633 (-3.2A)SAM A4633 (-3.4A)SAM A4633 (-3.4A)SAM A4633 (-3.5A)SAM A4633 (-4.5A)SAM A4633 (-3.6A)SAM A4633 (-3.4A)SAM A4633 (-3.7A)SAM A4633 ( 4.2A) | 0.43A | 5njvA-3eluA:39.3 | 5njvA-3eluA:54.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evc | RNA-DIRECTED RNAPOLYMERASE NS5 (Yellow fevervirus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131ASP A 146ILE A 147 | SAH A 901 (-3.2A)SAH A 901 (-3.4A)SAH A 901 (-3.3A)SAH A 901 (-3.1A)SAH A 901 (-3.6A)SAH A 901 (-4.5A)SAH A 901 (-3.8A)SAH A 901 (-3.7A)SAH A 901 (-3.8A)SAH A 901 ( 4.2A) | 0.22A | 5njvA-3evcA:41.4 | 5njvA-3evcA:53.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evc | RNA-DIRECTED RNAPOLYMERASE NS5 (Yellow fevervirus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SAH A 901 (-3.4A)SAH A 901 (-3.2A)SAH A 901 (-3.1A)SAH A 901 (-3.3A)NoneSAH A 901 (-3.8A) | 1.30A | 5njvA-3evcA:41.4 | 5njvA-3evcA:53.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f8r | THIOREDOXINREDUCTASE (TRXB-3) (Sulfolobussolfataricus) |
PF07992(Pyr_redox_2) | 5 | GLY A 305GLY A 22GLY A 24GLY A 29ILE A 121 | NoneNAP A4005 (-3.1A)NAP A4005 (-3.3A)NoneNAP A4005 (-3.8A) | 0.90A | 5njvA-3f8rA:undetectable | 5njvA-3f8rA:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fq8 | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE (Synechococcuselongatus) |
PF00202(Aminotran_3) | 6 | GLY A1282GLY A1316GLY A1277GLY A1272THR A1319ILE A1317 | None | 1.48A | 5njvA-3fq8A:undetectable | 5njvA-3fq8A:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g01 | GRANZYME C (Mus musculus) |
PF00089(Trypsin) | 5 | GLY A 149GLY A 52GLY A 206GLY A 202VAL A 60 | None | 0.83A | 5njvA-3g01A:undetectable | 5njvA-3g01A:20.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gcz | POLYPROTEIN (Yokose virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A4633 (-3.5A)SAM A4633 (-3.4A)SAM A4633 (-3.4A)SAM A4633 (-3.2A)SAM A4633 (-3.6A)SAM A4633 (-4.5A)SAM A4633 (-3.5A)SAM A4633 (-3.7A)SAM A4633 (-3.6A)SAM A4633 (-3.7A)SAM A4633 ( 4.2A) | 0.37A | 5njvA-3gczA:41.7 | 5njvA-3gczA:56.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h41 | NLP/P60 FAMILYPROTEIN (Bacillus cereus) |
PF00877(NLPC_P60) | 5 | GLY A 235GLY A 218GLY A 233THR A 217ILE A 302 | None | 0.89A | 5njvA-3h41A:undetectable | 5njvA-3h41A:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h7t | GROUP 3 ALLERGENSMIPP-S YVT004A06 (Sarcoptesscabiei) |
PF00089(Trypsin) | 6 | GLY A 126GLY A 28GLY A 187GLY A 184THR A 38VAL A 36 | None | 1.29A | 5njvA-3h7tA:undetectable | 5njvA-3h7tA:19.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lgi | PROTEASE DEGS (Escherichiacoli) |
PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.75A | 5njvA-3lgiA:undetectable | 5njvA-3lgiA:23.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.38A | 5njvA-3lkzA:41.9 | 5njvA-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.49A | 5njvA-3lkzA:41.9 | 5njvA-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.35A | 5njvA-3lkzA:41.9 | 5njvA-3lkzA:63.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nlc | UNCHARACTERIZEDPROTEIN VP0956 (Vibrioparahaemolyticus) |
no annotation | 5 | GLY A 264GLY A 162GLY A 160THR A 163ILE A 514 | FAD A 601 (-3.2A)FAD A 601 (-3.1A)FAD A 601 (-3.4A)NoneFAD A 601 (-3.9A) | 0.83A | 5njvA-3nlcA:undetectable | 5njvA-3nlcA:17.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pea | ENOYL-COAHYDRATASE/ISOMERASEFAMILY PROTEIN (Bacillusanthracis) |
PF00378(ECH_1) | 5 | GLY A 62GLY A 84GLY A 110THR A 87HIS A 32 | None | 0.70A | 5njvA-3peaA:undetectable | 5njvA-3peaA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pv2 | DEGQ (Legionellafallonii) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 206GLY A 69GLY A 194VAL A 94ILE A 79 | None | 0.85A | 5njvA-3pv2A:undetectable | 5njvA-3pv2A:21.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pv4 | DEGQ (Legionellafallonii) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 206GLY A 69GLY A 194VAL A 94ILE A 79 | None | 0.86A | 5njvA-3pv4A:undetectable | 5njvA-3pv4A:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r24 | 2'-O-METHYLTRANSFERASE (Severe acuterespiratorysyndrome-relatedcoronavirus) |
PF06460(NSP13) | 5 | GLY A 71GLY A 73GLY A 81ASP A 114ASP A 130 | SAM A 302 (-3.7A)SAM A 302 (-4.1A)SAM A 302 (-3.4A)SAM A 302 (-3.4A)SAM A 302 (-3.6A) | 0.88A | 5njvA-3r24A:10.6 | 5njvA-3r24A:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s69 | THROMBIN-LIKE ENZYMEDEFIBRASE (Gloydiussaxatilis) |
PF00089(Trypsin) | 6 | GLY A 139GLY A 43GLY A 196GLY A 193THR A 53VAL A 51 | None | 1.29A | 5njvA-3s69A:undetectable | 5njvA-3s69A:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s9b | VIPERA RUSSELLIPROTEINASE RVV-VGAMMA (Daboiasiamensis) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.26A | 5njvA-3s9bA:undetectable | 5njvA-3s9bA:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ugk | SACCHAROPINEDEHYDROGENASE [NAD+,L-LYSINE-FORMING] (Saccharomycescerevisiae) |
PF05222(AlaDh_PNT_N) | 5 | GLY A 140GLY A 200GLY A 203GLY A 208ILE A 250 | None | 0.87A | 5njvA-3ugkA:undetectable | 5njvA-3ugkA:21.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vml | 3-ISOPROPYLMALATEDEHYDROGENASE (Shewanellabenthica;Shewanellaoneidensis) |
PF00180(Iso_dh) | 5 | GLY A 14GLY A 45GLY A 75GLY A 12ASP A 86 | None | 0.85A | 5njvA-3vmlA:undetectable | 5njvA-3vmlA:22.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w9h | ACRIFLAVINERESISTANCE PROTEIN B (Escherichiacoli) |
PF00873(ACR_tran) | 5 | GLY A 290GLY A 288GLY A 179ASP A 328ILE A 291 | None | 0.85A | 5njvA-3w9hA:undetectable | 5njvA-3w9hA:13.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zk4 | DIPHOSPHONUCLEOTIDEPHOSPHATASE 1 (Lupinus luteus) |
PF00149(Metallophos)PF14008(Metallophos_C)PF16656(Pur_ac_phosph_N) | 6 | GLY A 274GLY A 476GLY A 271GLY A 516VAL A 437ASP A 313 | NoneNoneNoneNoneNone MN A 801 (-2.6A) | 1.42A | 5njvA-3zk4A:undetectable | 5njvA-3zk4A:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a9w | MONOOXYGENASE (Stenotrophomonasmaltophilia) |
PF13738(Pyr_redox_3) | 5 | GLY A 11GLY A 321GLY A 129GLY A 10ASP A 324 | FAD A1353 ( 4.7A)FAD A1353 ( 4.5A)FAD A1353 (-3.6A)FAD A1353 (-3.0A)SO4 A1359 (-3.6A) | 0.89A | 5njvA-4a9wA:undetectable | 5njvA-4a9wA:19.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cjx | C-1-TETRAHYDROFOLATESYNTHASE,CYTOPLASMIC,PUTATIVE (Trypanosomabrucei) |
PF00763(THF_DHG_CYH)PF02882(THF_DHG_CYH_C) | 5 | GLY A 172GLY A 237GLY A 217GLY A 170VAL A 271 | NAP A1301 (-3.3A)NAP A1301 (-3.3A)NAP A1301 (-2.8A)NAP A1301 (-3.3A)None | 0.84A | 5njvA-4cjxA:4.3 | 5njvA-4cjxA:22.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e7n | SNAKE-VENOMTHROMBIN-LIKE ENZYME (Gloydius halys) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.27A | 5njvA-4e7nA:undetectable | 5njvA-4e7nA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gc5 | DIMETHYLADENOSINETRANSFERASE 1,MITOCHONDRIAL (Mus musculus) |
PF00398(RrnaAD) | 5 | GLY A 63GLY A 65GLY A 68ASP A 111VAL A 112 | ACT A 402 (-3.4A)NoneNoneNoneNone | 0.59A | 5njvA-4gc5A:8.1 | 5njvA-4gc5A:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ibo | GLUCONATEDEHYDROGENASE (Agrobacteriumfabrum) |
PF13561(adh_short_C2) | 5 | GLY A 22GLY A 97GLY A 24ASP A 117ILE A 98 | None | 0.88A | 5njvA-4iboA:2.2 | 5njvA-4iboA:24.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ikh | GLUTATHIONES-TRANSFERASE (Pseudomonasprotegens) |
PF00043(GST_C)PF02798(GST_N) | 5 | GLY A 134GLY A 131ASP A 165VAL A 211ILE A 205 | NoneGSH A 303 (-3.3A)NoneNoneNone | 0.88A | 5njvA-4ikhA:undetectable | 5njvA-4ikhA:23.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k6m | POLYPROTEIN (Japaneseencephalitisvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.1A)SAH A1001 (-3.3A)SAH A1001 ( 3.7A)SAH A1001 (-3.2A)SAH A1001 (-3.9A)SAH A1001 (-4.7A)NoneSAH A1001 ( 3.6A)SAH A1001 (-3.7A)SAH A1001 (-3.7A)SAH A1001 (-3.6A)SAH A1001 ( 4.3A) | 0.60A | 5njvA-4k6mA:41.6 | 5njvA-4k6mA:68.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lrs | ACETALDEHYDEDEHYDROGENASE (Thermomonosporacurvata) |
PF01118(Semialdhyde_dh)PF09290(AcetDehyd-dimer) | 6 | GLY B 181GLY B 35GLY B 32GLY B 179THR B 36ILE B 28 | PEG B 409 ( 3.5A)NoneNAD B 401 (-3.2A)NAD B 401 (-3.5A)NoneNone | 1.22A | 5njvA-4lrsB:4.0 | 5njvA-4lrsB:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n49 | CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1 (Homo sapiens) |
PF01728(FtsJ) | 5 | GLY A 279GLY A 282THR A 301ASP A 335ASP A 364 | SAM A 601 (-3.5A)SAM A 601 (-3.1A)SAM A 601 (-4.1A)SAM A 601 (-3.6A)SAM A 601 (-3.6A) | 0.56A | 5njvA-4n49A:15.6 | 5njvA-4n49A:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ra6 | L-ASPARAGINASE (Pyrococcusfuriosus) |
no annotation | 5 | GLY B 288GLY B 231GLY B 235GLY B 267ILE B 229 | None | 0.86A | 5njvA-4ra6B:undetectable | 5njvA-4ra6B:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ynn | PROTEASE DO (Legionellapneumophila) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 203GLY A 66GLY A 191VAL A 91ILE A 76 | None | 0.76A | 5njvA-4ynnA:undetectable | 5njvA-4ynnA:20.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yo1 | DEGQ (Legionellapneumophila) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 203GLY A 66GLY A 191VAL A 91ILE A 76 | None | 0.83A | 5njvA-4yo1A:undetectable | 5njvA-4yo1A:23.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a22 | VESICULAR STOMATITISVIRUS L POLYMERASE (Vesicularstomatitisvirus) |
PF00946(Mononeg_RNA_pol)PF14314(Methyltrans_Mon)PF14318(Mononeg_mRNAcap) | 5 | GLY A1670GLY A1672GLY A1675ASP A1735ASP A1762 | None | 0.82A | 5njvA-5a22A:12.2 | 5njvA-5a22A:8.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5aa5 | NIFE-HYDROGENASESMALL SUBUNIT, HOFKNIFE-HYDROGENASELARGE SUBUNIT, HOFG (Cupriavidusnecator;Cupriavidusnecator) |
PF01058(Oxidored_q6)PF14720(NiFe_hyd_SSU_C)PF00374(NiFeSe_Hases) | 6 | GLY C 82HIS C 88ASP C 86VAL C 205ASP A 33ILE C 83 | NoneNFU C 701 (-3.6A)NoneNoneNoneNone | 1.38A | 5njvA-5aa5C:undetectable | 5njvA-5aa5C:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ccx | TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASECATALYTIC SUBUNITTRMT61A (Homo sapiens) |
PF08704(GCD14) | 6 | GLY A 111GLY A 113ASP A 163VAL A 164ASP A 181ILE A 182 | SAH A 301 (-3.2A)SAH A 301 (-2.9A)SAH A 301 (-2.7A)SAH A 301 (-4.0A)SAH A 301 (-2.4A)SAH A 301 ( 3.8A) | 0.83A | 5njvA-5ccxA:8.8 | 5njvA-5ccxA:25.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ccx | TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASECATALYTIC SUBUNITTRMT61A (Homo sapiens) |
PF08704(GCD14) | 6 | GLY A 111GLY A 115ASP A 163VAL A 164ASP A 181ILE A 182 | SAH A 301 (-3.2A)SAH A 301 (-3.9A)SAH A 301 (-2.7A)SAH A 301 (-4.0A)SAH A 301 (-2.4A)SAH A 301 ( 3.8A) | 0.93A | 5njvA-5ccxA:8.8 | 5njvA-5ccxA:25.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dd5 | ANTI-HIV ANTIBODYDH570.9 FAB HEAVYCHAINANTI-HIV ANTIBODYDH570.9 FAB HEAVYCHAIN (Macaca mulatta;Macaca mulatta) |
PF07654(C1-set)PF07686(V-set)PF07654(C1-set)PF07686(V-set) | 5 | GLY H 35GLY H 106GLY H 104LYS L 42ILE H 89 | None | 0.85A | 5njvA-5dd5H:undetectable | 5njvA-5dd5H:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e7q | ACYL-COA SYNTHETASE (Streptomycesplatensis) |
PF00501(AMP-binding)PF13193(AMP-binding_C) | 5 | GLY A 308GLY A 318GLY A 312GLY A 310ILE A 216 | SO4 A 709 ( 3.9A)NoneNoneNoneNone | 0.89A | 5njvA-5e7qA:undetectable | 5njvA-5e7qA:18.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e9q | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A 301 (-3.2A)SAM A 301 (-3.3A)SAM A 301 (-3.1A)SAM A 301 (-3.1A)SAM A 301 (-3.6A)SAM A 301 (-4.6A)NoneSAM A 301 ( 3.7A)SAM A 301 (-3.4A)SAM A 301 (-3.6A)SAM A 301 (-3.8A)SAM A 301 ( 4.2A) | 0.32A | 5njvA-5e9qA:41.7 | 5njvA-5e9qA:64.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e9q | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 6 | GLY A 58TRP A 87HIS A 110ASP A 131ASP A 146ILE A 147 | SAM A 301 (-3.2A)SAM A 301 (-3.6A)SAM A 301 ( 3.7A)SAM A 301 (-3.4A)SAM A 301 (-3.8A)SAM A 301 ( 4.2A) | 1.47A | 5njvA-5e9qA:41.7 | 5njvA-5e9qA:64.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e9q | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 6 | GLY A 86TRP A 87LYS A 105HIS A 110ASP A 146ILE A 147 | SAM A 301 (-3.1A)SAM A 301 (-3.6A)NoneSAM A 301 ( 3.7A)SAM A 301 (-3.8A)SAM A 301 ( 4.2A) | 1.37A | 5njvA-5e9qA:41.7 | 5njvA-5e9qA:64.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5erg | TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASECATALYTIC SUBUNITTRM61 (Saccharomycescerevisiae) |
PF08704(GCD14) | 5 | GLY B 118GLY B 120ASP B 168VAL B 169ASP B 203 | SAM B 401 (-3.4A)SAM B 401 (-3.3A)SAM B 401 (-3.5A)SAM B 401 (-3.7A)SAM B 401 (-3.3A) | 0.90A | 5njvA-5ergB:8.6 | 5njvA-5ergB:23.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gnd | PUTATIVE SERINEPROTEASE HHOA (Synechocystissp. PCC 6803) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 250GLY A 114GLY A 238VAL A 138ILE A 123 | None | 0.90A | 5njvA-5gndA:undetectable | 5njvA-5gndA:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gp4 | GLUTAMATEDECARBOXYLASE (Lactobacillusbrevis) |
no annotation | 5 | GLY C 288GLY C 329GLY C 277TRP C 289ILE C 328 | None | 0.85A | 5njvA-5gp4C:2.1 | 5njvA-5gp4C:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvt | PLASMA KALLIKREIN (Mus musculus) |
no annotation | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.28A | 5njvA-5gvtA:undetectable | 5njvA-5gvtA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hdm | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE1, CHLOROPLASTIC (Arabidopsisthaliana) |
PF00202(Aminotran_3) | 6 | GLY A 283GLY A 317GLY A 278GLY A 273THR A 320ILE A 318 | None | 1.43A | 5njvA-5hdmA:undetectable | 5njvA-5hdmA:21.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hxw | L-AMINO ACIDDEAMINASE (Proteusvulgaris) |
PF01266(DAO) | 5 | GLY A 66GLY A 257GLY A 61VAL A 271ILE A 420 | NoneFAD A 501 (-3.4A)FAD A 501 (-3.1A)NoneNone | 0.89A | 5njvA-5hxwA:undetectable | 5njvA-5hxwA:20.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A 311 (-3.3A)SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-3.5A)SAM A 311 (-4.5A)SAM A 311 (-4.1A)MLT A 313 ( 2.6A)SAM A 311 (-3.7A)SAM A 311 (-3.8A)SAM A 311 ( 4.3A) | 0.25A | 5njvA-5ikmA:41.2 | 5njvA-5ikmA:62.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146 | SAM A 311 (-3.3A)SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-3.5A)SAM A 311 (-4.5A)MLT A 313 ( 3.0A)SAM A 311 (-4.1A)MLT A 313 ( 2.6A)SAM A 311 (-3.7A)SAM A 311 (-3.8A) | 0.76A | 5njvA-5ikmA:41.2 | 5njvA-5ikmA:62.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)NoneSAM A 311 (-3.8A) | 1.30A | 5njvA-5ikmA:41.2 | 5njvA-5ikmA:62.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jd8 | PERIPLASMIC SERINEPEPTIDASE DEGS (Yersinia pestis) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 213GLY A 82GLY A 201VAL A 106ILE A 91 | None | 0.73A | 5njvA-5jd8A:undetectable | 5njvA-5jd8A:21.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jjr | GENOME POLYPROTEIN (Dengue virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1003 (-3.2A)SAH A1003 (-3.4A)SAH A1003 (-3.5A)SAH A1003 (-3.0A)SAH A1003 (-3.4A)SAH A1003 (-4.6A)SAH A1003 (-3.7A)SAH A1003 (-3.0A)SAH A1003 (-3.7A)SAH A1003 (-3.8A)SAH A1003 ( 4.3A) | 0.36A | 5njvA-5jjrA:41.1 | 5njvA-5jjrA:31.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jjr | GENOME POLYPROTEIN (Dengue virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146 | SAH A1003 (-3.2A)SAH A1003 (-3.4A)SAH A1003 (-3.5A)SAH A1003 (-3.0A)SAH A1003 (-3.4A)SAH A1003 (-4.6A)SAH A1003 (-4.8A)SAH A1003 (-3.7A)SAH A1003 (-3.7A)SAH A1003 (-3.8A) | 0.69A | 5njvA-5jjrA:41.1 | 5njvA-5jjrA:31.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jjr | GENOME POLYPROTEIN (Dengue virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 6 | GLY A 58TRP A 87HIS A 110ASP A 131ASP A 146ILE A 147 | SAH A1003 (-3.2A)SAH A1003 (-3.4A)SAH A1003 (-3.7A)SAH A1003 (-3.0A)SAH A1003 (-3.8A)SAH A1003 ( 4.3A) | 1.44A | 5njvA-5jjrA:41.1 | 5njvA-5jjrA:31.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jy1 | PUTATIVE SHORT-CHAINDEHYDROGENASE/REDUCTASE (Paraburkholderiaxenovorans) |
PF13561(adh_short_C2) | 5 | GLY A 13GLY A 15GLY A 21ASP A 63VAL A 64 | NAD A 301 (-3.4A)NAD A 301 ( 4.2A)NoneNAD A 301 (-3.8A)NAD A 301 (-3.6A) | 0.90A | 5njvA-5jy1A:5.4 | 5njvA-5jy1A:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kpg | PAVINEN-METHYLTRANSFERASE (Thalictrumflavum) |
PF02353(CMAS) | 5 | GLY A 135GLY A 137THR A 158ASP A 185VAL A 186 | SAH A 401 (-3.7A)SAH A 401 ( 3.8A)NoneSAH A 401 (-3.5A)SAH A 401 (-3.8A) | 0.58A | 5njvA-5kpgA:8.0 | 5njvA-5kpgA:21.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nju | GENOME POLYPROTEIN (Zika virus) |
no annotation | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.3A)SAH A1001 (-3.4A)SAH A1001 (-3.4A)SAH A1001 (-3.3A)SAH A1001 (-3.5A)SAH A1001 (-4.4A)SAH A1001 (-4.0A)SAH A1001 (-3.9A)SAH A1001 (-3.6A)SAH A1001 (-3.7A)SAH A1001 (-4.2A) | 0.34A | 5njvA-5njuA:43.5 | 5njvA-5njuA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nju | GENOME POLYPROTEIN (Zika virus) |
no annotation | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.3A)SAH A1001 (-3.4A)SAH A1001 (-3.4A)SAH A1001 (-3.3A)SAH A1001 (-3.5A)SAH A1001 (-4.4A)NoneSAH A1001 (-3.9A)SAH A1001 (-3.6A)SAH A1001 (-3.7A)SAH A1001 (-4.2A) | 0.53A | 5njvA-5njuA:43.5 | 5njvA-5njuA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nju | GENOME POLYPROTEIN (Zika virus) |
no annotation | 6 | GLY A 58TRP A 87HIS A 110VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.3A)SAH A1001 (-3.5A)SAH A1001 (-4.0A)SAH A1001 (-3.6A)SAH A1001 (-3.7A)SAH A1001 (-4.2A) | 1.45A | 5njvA-5njuA:43.5 | 5njvA-5njuA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nju | GENOME POLYPROTEIN (Zika virus) |
no annotation | 6 | GLY A 86TRP A 87LYS A 105ASP A 131ASP A 146ILE A 147 | SAH A1001 (-3.3A)SAH A1001 (-3.5A)NoneSAH A1001 (-3.9A)SAH A1001 (-3.7A)SAH A1001 (-4.2A) | 1.50A | 5njvA-5njuA:43.5 | 5njvA-5njuA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5svc | ACETONE CARBOXYLASEALPHA SUBUNIT (Xanthobacterautotrophicus) |
PF02538(Hydantoinase_B) | 5 | GLY A 510GLY A 431GLY A 464GLY A 627ASP A 545 | None | 0.86A | 5njvA-5svcA:undetectable | 5njvA-5svcA:14.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tmh | POLYPROTEIN (Zika virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.2A)SAH A1001 (-3.4A)SAH A1001 ( 3.8A)SAH A1001 (-3.6A)SAH A1001 (-3.5A)SAH A1001 ( 4.9A)SAH A1001 (-3.6A)SAH A1001 (-4.0A)SAH A1001 (-4.0A)SAH A1001 (-3.8A)SAH A1001 ( 4.8A) | 0.34A | 5njvA-5tmhA:42.4 | 5njvA-5tmhA:96.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u4q | DTDP-GLUCOSE4,6-DEHYDRATASE (Klebsiellapneumoniae) |
PF16363(GDP_Man_Dehyd) | 5 | GLY A 183GLY A 13GLY A 186VAL A 5ILE A 16 | CL A 402 (-4.3A)None CL A 402 ( 4.4A)NoneNone | 0.79A | 5njvA-5u4qA:5.5 | 5njvA-5u4qA:20.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6day | DIHYDROPTEROATESYNTHASE (Xanthomonasalbilineans) |
no annotation | 5 | GLY A 24HIS A 249ASP A 264ASP A 61ILE A 25 | NoneNoneNoneNoneSO4 A 403 (-4.3A) | 0.86A | 5njvA-6dayA:undetectable | 5njvA-6dayA:undetectable |